Disposable Versus Reusable drApes and Gowns for Green OperatiNg Theatres (DRAGON)
Multicentre Non-inferiority Cluster Randomised Trial Testing Disposable Versus Reusable drApes and Gowns for Green OperatiNg Theatres
Multicentre non-inferiority cluster randomised trial testing Disposable versus Reusable drApes and Gowns for green OperatiNg theatres. A pragmatic 1:1 international multi-centre non-inferiority cluster randomised controlled trial, with an internal pilot. Clusters are individual hospitals.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
Background: The World Health Organisation makes no recommendation for the use of disposable or reusable surgical drapes and gowns due to a lack of effectiveness evidence. Since disposable versions are likely to have higher financial and carbon costs, they are only justifiable if they can be proven to significantly reduce surgical site infections (SSIs).
Aim: This randomised controlled trial will assess whether reusable surgical drapes and gowns are non-inferior in reducing SSI compared to disposable drapes and gowns in patients undergoing surgery.
Design: Pragmatic 1:1 international multi-centre non-inferiority cluster randomised controlled trial, with an internal pilot. Clusters are individual hospitals.
Intervention: Reusable surgical drapes and gowns.
Comparator: Disposable (single-use) surgical drapes and gowns.
Sample size: The control group SSI event rate is estimated to be 12.5% based on previous literature. To determine whether reusable drapes and gowns are non-inferior to disposable drapes and gowns with a non-inferiority margin of 2.5% would require a total of 26,800 participants from 134 clusters, with an average of 200 participants per cluster, assuming 90% power, 2.5% one-sided alpha, intraclass correlation of 0.01 and 5% participant loss to follow up.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Rachel Lillywhite
- Telefonnummer: 07739743528
- E-mail: r.e.lillywhite@bham.ac.uk
Undersøgelse Kontakt Backup
- Navn: Divya Kapoor
- Telefonnummer: +44 (0)121 415 9103
- E-mail: d.kapoor@bham.ac.uk
Studiesteder
-
-
-
Cotonou, Benin
- Rekruttering
- University of Abomey Calavi
-
Kontakt:
- Ismail Lawani
- Telefonnummer: +22967193929
- E-mail: ismaillawani@gmail.com
-
-
-
-
-
Tamale, Ghana
- Aktiv, ikke rekrutterende
- Tamale Teaching Hospital, Tamale
-
-
-
-
-
Ludhiana, Indien
- Rekruttering
- Christian Medical College and Hospital Ludhiana
-
Kontakt:
- Dhruv Ghosh
- Telefonnummer: +919915198894
- E-mail: dhruvghosh73@gmail.com
-
-
-
-
-
Guadalajara, Mexico
- Afsluttet
- CMNO
-
-
-
-
-
Lagos, Nigeria
- Rekruttering
- Lagos University Teaching Hospital (Hub), Lagos
-
Kontakt:
- Adesoji Ademuyiwa
- E-mail: adesojiademuyiwa@yahoo.co.uk
-
-
-
-
-
Kigali, Rwanda
- Rekruttering
- University Teaching Hospital of Kigali (Hub)
-
Kontakt:
- Jean de la Croix Allen
- E-mail: ijea2000@gmail.com
-
-
-
-
-
Johannesburg, Sydafrika
- Aktiv, ikke rekrutterende
- University of the Witwatersrand
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion criteria:
- Patients with at least one incision that is ≥5cm in adults and ≥3cm in children aged under 16 years. This can include both open and minimally-invasive surgery providing at least one incision meets this criteria.
- Patients with a clean-contaminated, contaminated, or dirty surgical wound. Definitions of contamination are given in Table 2.
- Patients undergoing emergency (surgery on an unplanned admission) or elective (surgery on a planned admission) surgery.
- Any operative indication (including caesarean section).
- Patients aged 10 or over.
Exclusion criteria
- Adults with an incision <5 cm and incision <3cm in children aged under 16 years.
- Patients undergoing procedures with a clean surgical wound only.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Intervention: Reusable drapes and gowns
|
Reusable drapes and gowns used during surgery. |
|
Aktiv komparator: Comparator: Disposable (single-use) drapes and gowns
|
Disposable drapes and gowns used during surgery. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Surgical site infection (SSI)
Tidsramme: Within 30 days of surgery
|
SSI according to centre for disease control (CDC) criteria: The infection must occur within 30-days of the index operation AND The infection must involve the skin, subcutaneous, muscular, or fascial layers of the incision AND The patient must have at least one of the following: Purulent drainage from the wound Organisms are detected from a wound swab Wound opened spontaneously or by a clinician AND, at the surgical wound, the patient has at least one of pain or tenderness; localised swelling; redness; heat; systemic fever (>38°C). Diagnosis of SSI by a clinician or on imaging |
Within 30 days of surgery
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Dødelighed (og sandsynlig årsag)
Tidsramme: Inden for 30 dage efter operationen
|
Inden for 30 dage efter operationen
|
|
Uplanlagt såråbning
Tidsramme: Inden for 30 dage efter operationen
|
Inden for 30 dage efter operationen
|
|
Antibiotikaordination til SSI
Tidsramme: Inden for 30 dage efter operationen
|
Inden for 30 dage efter operationen
|
|
Genoptagelse på akutmodtagelse
Tidsramme: Inden for 30 dage efter operationen
|
Inden for 30 dage efter operationen
|
|
Genindlæggelse på hospitalet
Tidsramme: Inden for 30 dage efter operationen
|
Inden for 30 dage efter operationen
|
|
Reoperation for SSI
Tidsramme: Inden for 30 dage efter operationen
|
Inden for 30 dage efter operationen
|
|
Samlet længde af hospitalsophold
Tidsramme: Inden for 30 dage efter operationen
|
Inden for 30 dage efter operationen
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Ledende efterforsker: Aneel Bhangu, University of Birmingham
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- RG_22-181 - Q1085
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Hospital-level data will not be released or published. Country-level analyses will only be conducted with permission of lead investigators from each participating country. Local investigators may access their data across their country to perform country-level analyses (all participating hospitals should consent to their data being used in this way).
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .